Total investments 13
Average round size 
$136M
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 0
Follow on index
0.31How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Mark Foundation for Cancer Research:
Typical Co-investors
The Mark Foundation for Cancer Research is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Mark Foundation for Cancer Research:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Access Computech | - |
| Amana | Chiyoda, Japan |
| Essex Investment Management | Boston, Massachusetts, United States |
| eXeed Technology | HaMerkaz, Israel, Savyon |
| Fuchengwan Touzi | China, Guangdong, Tianjin |
| Government of British Columbia | British Columbia, Canada, Victoria |
| Govtech Fund | California, San Francisco, United States |
| Iridium Ventures | - |
| Kleinwort Benson | England, London, United Kingdom |
| Monoful | Chiyoda, Japan |
| Nobska Ventures | Maryland, Stevenson, United States |
| Runwu Konggu | Beijing, China, Haidian |
| SALIC | Ar Riyad, Riyadh, Saudi Arabia |
| Shenzhen Taikong Technology | China, Guangdong, Shenzhen |
| Taiho Ventures | California, California City, United States |
| TechnoCap | Canada, Montréal, Quebec |
| UNION CAPITAL | Beijing, Beijing, China |
| V-CUBE | California, Torrance, United States |
| Wemind | - |
| Winton Labs | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Accent Therapeutics | $75M | 23 Jan 2024 | Lexington, Kentucky, United States | ||
Hyku | $56M | 19 Sep 2023 | Lexington, Kentucky, United States | ||
Vicinitas Therapeutics | $65M | 28 Jul 2022 | San Francisco, California, United States | ||
Immunitas Therapeutics | $58M | 18 Aug 2021 | Cambridge, Massachusetts, United States | ||
Interius BioTherapeutics | $76M | 18 May 2021 | Philadelphia, Pennsylvania, United States | ||
C2i Genomics | $100M | 15 Apr 2021 | New York, New York, United States | ||
C2i Genomics | $12M | 09 Jun 2020 | New York, New York, United States | ||
Accent Therapeutics | $63M | 23 Apr 2020 | Lexington, Kentucky, United States | ||
Interius BioTherapeutics | $5M | 13 Mar 2020 | Philadelphia, Pennsylvania, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent The Mark Foundation for Cancer Research?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 13
Average round size 136M
Peak activity year 2020
Lead investments 0
Follow on index 0.31
Exits 1
Group Appearance index 0.92
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Accent Therapeutics | $75M | 23 Jan 2024 | Lexington, Kentucky, United States | ||
Hyku | $56M | 19 Sep 2023 | Lexington, Kentucky, United States | ||
Vicinitas Therapeutics | $65M | 28 Jul 2022 | San Francisco, California, United States | ||
Immunitas Therapeutics | $58M | 18 Aug 2021 | Cambridge, Massachusetts, United States | ||
Interius BioTherapeutics | $76M | 18 May 2021 | Philadelphia, Pennsylvania, United States | ||
C2i Genomics | $100M | 15 Apr 2021 | New York, New York, United States | ||
C2i Genomics | $12M | 09 Jun 2020 | New York, New York, United States | ||
Accent Therapeutics | $63M | 23 Apr 2020 | Lexington, Kentucky, United States | ||
Interius BioTherapeutics | $5M | 13 Mar 2020 | Philadelphia, Pennsylvania, United States |
